DanCann Pharma A/S (NGM:DANCAN)
Sweden
· Delayed Price · Currency is SEK · Price in DKK 1.350
+0.100 (8.00%)
At close: Apr 15, 2025
DanCann Pharma Balance Sheet
Financials in millions DKK. Fiscal year is January - December.
Millions DKK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Cash & Equivalents | 3.47 | 2.01 | 10.75 | 7.74 | 21.33 | Upgrade
|
| Cash & Short-Term Investments | 3.47 | 2.01 | 10.75 | 7.74 | 21.33 | Upgrade
|
| Cash Growth | 73.13% | -81.34% | 38.97% | -63.73% | 11791.01% | Upgrade
|
| Accounts Receivable | 0.17 | - | 1.61 | 0.53 | - | Upgrade
|
| Other Receivables | 0.18 | 0.4 | 3.14 | 8.64 | 7.57 | Upgrade
|
| Receivables | 0.35 | 0.4 | 4.75 | 9.17 | 7.57 | Upgrade
|
| Inventory | 0.34 | 0.34 | 0.34 | 0.27 | 0.01 | Upgrade
|
| Prepaid Expenses | 0.34 | 0.44 | 0.47 | 0.48 | 0.66 | Upgrade
|
| Total Current Assets | 4.5 | 3.19 | 16.31 | 17.65 | 29.57 | Upgrade
|
| Property, Plant & Equipment | 3.19 | 3.94 | 9.28 | 9.57 | 3.98 | Upgrade
|
| Goodwill | 8.67 | 9.95 | 11.22 | 12.5 | - | Upgrade
|
| Other Intangible Assets | - | - | 36.56 | 28.95 | 15.68 | Upgrade
|
| Other Long-Term Assets | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 | Upgrade
|
| Total Assets | 16.67 | 17.39 | 73.7 | 68.99 | 49.55 | Upgrade
|
| Accounts Payable | 1.36 | 1.09 | 2.75 | 2.92 | 2.82 | Upgrade
|
| Short-Term Debt | - | 5.91 | 7.56 | - | - | Upgrade
|
| Current Portion of Leases | - | - | - | - | 0.19 | Upgrade
|
| Current Income Taxes Payable | - | - | - | 0.35 | - | Upgrade
|
| Other Current Liabilities | 0.41 | 0.88 | 0.6 | 11.38 | 0.86 | Upgrade
|
| Total Current Liabilities | 1.77 | 7.89 | 10.9 | 14.65 | 3.87 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | - | 0.97 | 1.34 | Upgrade
|
| Other Long-Term Liabilities | 0.28 | - | - | - | 0.02 | Upgrade
|
| Total Liabilities | 2.05 | 7.89 | 10.9 | 15.62 | 5.23 | Upgrade
|
| Common Stock | 3.99 | 5.31 | 2.44 | 1 | 0.78 | Upgrade
|
| Retained Earnings | 10.63 | 4.2 | 60.36 | 52.38 | 43.55 | Upgrade
|
| Shareholders' Equity | 14.62 | 9.51 | 62.79 | 53.37 | 44.33 | Upgrade
|
| Total Liabilities & Equity | 16.67 | 17.39 | 73.7 | 68.99 | 49.55 | Upgrade
|
| Total Debt | - | 5.91 | 7.56 | - | 0.19 | Upgrade
|
| Net Cash (Debt) | 3.47 | -3.91 | 3.19 | 7.74 | 21.15 | Upgrade
|
| Net Cash Growth | - | - | -58.71% | -63.42% | 11687.89% | Upgrade
|
| Net Cash Per Share | 0.87 | -27.59 | 49.13 | 342.36 | - | Upgrade
|
| Filing Date Shares Outstanding | 3.99 | 0.14 | 0.07 | 0.03 | 0.02 | Upgrade
|
| Total Common Shares Outstanding | 3.99 | 0.14 | 0.07 | 0.03 | 0.02 | Upgrade
|
| Working Capital | 2.73 | -4.7 | 5.41 | 3 | 25.7 | Upgrade
|
| Book Value Per Share | 3.66 | 67.12 | 965.82 | 2010.09 | 2138.10 | Upgrade
|
| Tangible Book Value | 5.95 | -0.44 | 15.02 | 11.92 | 28.64 | Upgrade
|
| Tangible Book Value Per Share | 1.49 | -3.10 | 230.95 | 448.91 | 1381.60 | Upgrade
|
| Machinery | 3.6 | 3.6 | 3.6 | 3.43 | 1.84 | Upgrade
|
| Construction In Progress | 0.1 | 0.1 | 3.35 | 3.32 | 1.95 | Upgrade
|
| Leasehold Improvements | 3.94 | 3.94 | 3.93 | 3.46 | 0.29 | Upgrade
|
Updated Feb 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.